Actionable insights straight to your inbox

Equities logo

Prestige Brands Holdings, Inc. Files SEC Form DEF 14A, Other Definitive Proxy Statements (Jul. 2, 2014)

By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission

By a News Reporter-Staff News Editor at Pharma Business Week — According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Prestige Brands Holdings, Inc. (Form DEF 14A) was posted on July 2, 2014.
The SIC code for this company is 2834, Pharmaceutical Preparations.
There were 3 documents filed with this form. The SEC file number is 0001144204-14-040925.
The contact information for this company is 660 WHITE PLAINS RD., TARRYTOWN NY 10591, (914) 524-6800.
Our editors provided additional information about Form DEF 14A: All other filed by non-management definitive proxy statements – typically an annual meeting proxy.
A U.S. Securities and Exchange Commission filing is a formal document or financial statement submitted to the SEC by publicly-traded companies.
For additional information on this SEC filing see: http://www.sec.gov/Archives/edgar/data/1295947/0001144204-14-040925-index.html.
Keywords for this news article include: Pharmaceutical Preparations, SEC Filing, Prestige Brands Holdings Inc..
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC

A weekly five-point roundup of critical events in fintech, the future of finance and the next wave of banking industry transformation.